Search Results - "Honeycutt, Christopher Cole"
-
1
Location bias contributes to functionally selective responses of biased CXCR3 agonists
Published in Nature communications (04-10-2022)“…Some G protein-coupled receptor (GPCR) ligands act as “biased agonists” that preferentially activate specific signaling transducers over others. Although GPCRs…”
Get full text
Journal Article -
2
Meropenem extraction by ex vivo extracorporeal life support circuits
Published in The Journal of extra-corporeal technology (01-12-2023)“…Meropenem is a broad-spectrum carbapenem-type antibiotic commonly used to treat critically ill patients infected with extended-spectrum β-lactamase…”
Get full text
Journal Article -
3
Assessment of Spanish Translation of Websites at Top-Ranked US Hospitals
Published in JAMA network open (01-02-2021)“…This cross-sectional study examines whether Spanish translation of top US hospital websites is associated with hospitals with public medical schools,…”
Get full text
Journal Article -
4
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis
Published in Communications biology (16-03-2023)“…Expanding the arsenal of prophylactic approaches against SARS-CoV-2 is of utmost importance, specifically those strategies that are resistant to antigenic…”
Get full text
Journal Article -
5
Biased agonism at chemokine receptors
Published in Cellular signalling (01-02-2021)“…In the human chemokine system, interactions between the approximately 50 known endogenous chemokine ligands and 20 known chemokine receptors (CKRs) regulate a…”
Get full text
Journal Article -
6
Assessment of Practices Affecting Racial and Ethnic COVID-19 Vaccination Equity in 10 Large US Cities
Published in Journal of public health management and practice (01-11-2022)“…In the United States, COVID-19 vaccines have been unequally distributed between different racial and ethnic groups. Public reporting of race and ethnicity data…”
Get full text
Journal Article -
7
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
Published in Nature communications (12-08-2024)“…SARS-CoV-2 has the capacity to evolve mutations that escape vaccine- and infection-acquired immunity and antiviral drugs. A variant-agnostic therapeutic agent…”
Get full text
Journal Article